Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans

Cancer Research

Volumn 60, Issue 4, 2000, Pages 950-956

  Guillemette, Chantal ^a   Millikan, Robert C ^b   Newman, Beth ^c   Housman, David E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b IL   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION INITIATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BREAST NEOPLASMS; FEMALE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0034652640     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Siegelmann-Danieli, N., and Buetow, K. H. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br. J. Cancer, 79: 456-631, 1999.
2. Haiman, C. A., Hankinson, S. E., Spiegelman, D., Colditz, C. A., Willett, W. C., Speizer, F. E., Kelsey, K. T., and Hunter, D. J. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res., 59: 1015-1020, 1999.
3. Bailey, L. R., Roodi, N., Dupont, W. D., and Parl, F. F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res., 58: 5038-5041, 1998.
4. Ishibe, N., Hankinson, S. E., Colditz, G. A., Spiegelman, D., Willett, W. C., Speizer, F. E., Kelsey, K. T., and Hunter, D. J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res., 58: 667-671, 1998.
5. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
6. Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadluhar, F. F., and Ambrosone, C. B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res., 58: 2107-2110, 1998.
7. Millikan, R. C., Pittman, G. S., Tse, C. K., Duell, E., Newman, B., Savitz, D., Moorman, P. G., Boissy, R. J., and Bell, D. A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (Lond.), 19: 1943-1947, 1998.
8. Bailey, L. R., Roodi, N., Verrier, C. S., Yee, C. J., Dupont, W. D., and Parl, F. F. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res., 58: 65-70, 1998.
9. Helzlsouer, K. J., Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W., and Bell, D. Association between glutathione S-transferase MI, PI, and TI genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst., 90: 512-518, 1998.
10. Millikan, R. C., Pittman, G. S., Newman, B., Tse, C. K., Selmin, O., Rockhill, B., Savitz, D., Moorman, P. G., and Bell, D. A. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 371-378, 1998.
11. Hunter, D. J., Hankinson, S. E., Hough, H., Gertig, D. M., Garcia-Closas, M., Spiegelman, D., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., and Kelsey, K. A. Prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis (Lond.), 18: 2127-2132, 1997.
12. Ambrosone, C. B., Freudenheim, J. L., Marshall, J. R., Graham, S., Vena, J. E., Brasure, J. R., Michalek, A. M., Laughlin, R., Nemoto, T., and Shields, P. G. The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk. Ann. NY Acad. Sci., 30: 250-252, 1995.
13. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J. R., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F., and Nebert, D. W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics, 7: 255-269, 1997.
14. Belanger, A., Hum, D. W., Beaulieu, M., Levesque, E., Guillemette, C., Tchernof, A., Belanger, G., Turgeon, D., and Dubois, S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J. Steroid Biochem. Mol. Biol., 65: 301-310, 1998.
15. Belanger, A., Caron, S., Labrie, F., Naldoni, C., Dogliotti, L., and Angeli, A. Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. Eur. J. Cancer, 26: 277-281, 1990.
16. Belanger, A., Labrie, F., and Angeli, A. Unconjugated and glucuronide steroid levels in human breast cyst fluid. Ann. NY Acad. Sci., 586: 93-100, 1990.
17. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst., 87: 190-197, 1995.
18. Zeleniuch-Jacquotte, A., Toniolo, P., Levitz, M., Shore, R. E., Koenig, K. L., Banerjee, S., Strax, P., and Pasternack, B. S. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 4: 857-860, 1995.
19. Cheng, Z., Rios, G. R., King, C. D., Coffman, B. L., Green, M. D., Mojarrabi, B., Mackenzie, P. I., and Tephly, T. R. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7. Toxicol. Sci., 45: 52-57, 1998.
20. Senafi, S. B., Clarke, D. J., and Burchell, B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J., 303: 233-240, 1994.
21. Ritter, J. K., Chen, F., Sheen, Y. Y., Lubet, R. A., and Owens, I. S. Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry, 31: 3409-3414, 1992.
22. Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N., Jansen, P. L., Oude Elferink, R. P., and Chowdury, N. K. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med., 333: 1171-1175, 1995.
23. Bosma, P., Chowdhury, J. R., and Jansen, P. H. Genetic inheritance of Gilbert's syndrome. Lancet, 346: 314-315, 1995.
24. Monaghan, G., Ryan, M., Seddon, R., Hume, R., and Burchell, B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet, 347: 578-581, 1996.
25. Beutler, E., Gelbart, T., and Demina, A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. USA, 95: 8170-8174, 1998.
26. Strassburg, C. P., Oldhafer, K., Manns, M. P., and Tukey, R. H. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol. Pharmacol., 52: 212-220, 1997.
27. Newman, B., Moorman, P., Millikan, R., Qaqish, B., Geradts, J., Aldrich, T., and Liu, E. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res. Treat., 35: 51-60, 1995.
28. Aldrich, T., Vann, D., Moorman, P., and Newman, B. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res. Treat., 35: 61-64, 1995.
29. Weinberg, C., and Sandler, D. Randomized recruitment in case-control studies. Am. J. Epidemiol., 1134: 421-432, 1999.
30. Moorman, P., Newman, B., Millikan, R., Tse, C-K., and Sandler, D. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann. Epidemiol., 9: 188-195, 1999.
31. Sambrook, J., Maniatis, T., and Fritsch, F. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1998.
32. Chou, Q., Russell, M., Birch, D. E., Raymond, J., and Bloch, W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-numher amplifications. Nucleic Acids Res., 20: 1717-1723, 1992.
33. Breslow, N., and Day, N. Statistical Methods in Cancer Research: The Analysis of Case-Control Studies. Lyon, France: IARC, 1980.
34. Cavalli-Sforza, L., and Bodiner, W. The Genetics of Human Populations. San Francisco, CA: W. H. Freeman, 1971.
35. Albin, N., Massaad, L., Toussaint, C., Mathieu, M. C., Morizet, J., Parise, O., Gouyette, A., and Chabot, G. G. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res., 53: 3541-3546, 1993.
36. Roy, R., Dauvois, S., Labrie, F., and Belanger, A. Estrogen-stimulated glucuronidation of dihydrotestosterone in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 41: 579-582, 1992.
37. Adams, J. B., Phillips, N. S., and Young, C. H. Formation of glucuronides of estradiol-17β by human mammary cancer cells. J. Steroid Biochem., 33: 1023-1025, 1989.
38. Prevost, J., and Belanger, A. Formation of estrogen glucuronides by human granulosa-luteal cells isolated from human menopausal gonadotropin-stimulated cycles for in vitro fertilization. Biol. Reprod., 38: 975-979, 1988.
39. Raju, U., Levitz, M., Kaganowicz, A., and Blaustein, A. Glucosiduronidation of androsterone by human breast tumors in vitro in relation to the progesterone receptor content. Steroids, 42: 449-455, 1983.
40. Raju, U., Kadner, S., Levitz, M., Kaganowicz, A., and Blaustein, A. Glucosiduronidation and esterificalion of androsterone by human breast tumors in vitro. Steroids, 37: 399-407, 1981.
41. Strassburg, C. P., Strassburg, A., Nguyen, N., Li, Q., Manns, M. P., and Tukey, R. H. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem. J., 338: 489-498, 1999.
42. Strassburg, C. P., Manns, M. P., and Tukey, R. H. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J. Biol. Chem., 273: 8719-8726, 1998.
43. Nandi, S., Guzman, R. C., and Yang, J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA, 92: 3650-3657, 1995.
44. Lopez-Otin, C., and Diamandis, E. P. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr. Rev., 19: 365-396, 1998.
45. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ranianathan, R., Cerny, R. L., and Rogan, E. G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
46. Zhu, B. T., and Conney, A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond.), 19: 1-27, 1998.
47. Zahm, S. H., and Fraumeni, J. F. Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ. Health Perspect., 103 (Suppl. 8); 283-286, 1995.
48. Eley, J. W., Hill, H. A., Chen, V. W., Austin, D. F., Wesley, M. N., Muss, H. B., Greenberg, R. S., Coates, R. J., Correa, P., Redmond, C. K., Hunter, C. P., Herman, A. A., Kurman, R., Blacklow, R., Shapiro, S., and Edwards, B. K. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. J. Am. Med. Assoc., 272: 947-954, 1994.
49. Howard, J., Hankey, B. F., Greenberg, R. S. Austin, D. F., Correa, P., Chen, V. W., and Durako, S. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer (Phila.), 69: 2349-2360, 1992.
50. Iyer, L., King, C. D., Whitington, P. F., Green, M, D., Roy, S. K., Tephly, T. R., Coffman, B. L., and Ratain, M. J. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J. Clin. Investig., 101: 847-854, 1998.
51. Labrie, F., Belanger, A., Cusan, L., and Candas, B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab., 82: 2403-2409, 1997.
52. de Morais, S. M., Uetrecht, J. P., and Wells, P. G. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology, 102: 577-586, 1992.
53. Taioli, F., Garte, S. J., Trachman, J., Garbers, S., Sepkovic, D. W., Osborne, M. P., Mehl, S., and Bradlow, H. L. Ethnic differences in estrogen metabolism in healthy women. J. Natl. Cancer Inst., 88: 617, 1996.